Estée Lauder FY2026 Earnings: $15.0B Sales, a Return to Profit, and Restructuring Between the Margins

Estée Lauder closed fiscal 2026 with $15.0 billion of net sales (+5% as reported, +3% organic) and $182 million of net earnings after a $1.1 billion loss a year earlier. Organic growth returned in every region — mainland China +9% — while as-reported operating margin flipped from (5.5)% to 5.2% and adjusted operating margin expanded 320 basis points to 11.2%. The year is a prestige-beauty turnaround ledger: the income statement is profitable again, but restructuring, impairments, and litigation still sit between reported and adjusted margin.

The Headline Numbers​

Fiscal year ended June 30, 2026 versus June 30, 2025 ($ in millions except EPS and margins):

The GAAP swing is large because FY2025 carried $1,286 million of goodwill and other intangible impairments and $159 million of talcum-litigation settlement charges. FY2026 still absorbed higher restructuring under the Profit Recovery and Growth Plan (PRGP) and an $84 million securities-class-action contingency, net of insurance. Strip those items and the company earned $2.51 of adjusted EPS on a 11.2% adjusted operating margin — the turnaround investors are meant to underwrite.

Q4 was the proof point management wanted: as-reported net sales +6% to about $3.63 billion, organic +5%, with growth across all geographic regions. Mainland China organic growth of 9% for the full year is the geographic headline that matters for prestige beauty.

Revenue Deep Dive: Skin, Fragrance, and China​

Organic net sales rose 3% for the year. Category commentary from the release (organic unless noted):

Skin Care is still the franchise. La Mer, The Ordinary, and Estée Lauder carried the +4% organic print. The Ordinary benefited from "targeted expanded consumer reach" and campaign timing into key shopping moments — classic prestige-brand language for distribution that is still opening, not closing.

Fragrance was the growth engine at +10% organic, with "double-digit growth from the Company’s Luxury Brands—with broad-based growth across brands as well as growth across all geographic regions." Angels' Share and Love, don't be shy franchises plus Angels' Share on the Rocks are the product-ramp story. Adjusted fragrance operating income +27% shows the mix is high-margin when it works.

Makeup was the repair job: growth improved more than 500 basis points versus prior year but finished "virtually flat." M·A·C's March 2026 launch in select markets and TOM FORD gains offset Bobbi Brown lip/eye softness and Too Faced declines.

Mainland China organic +9% led geographic growth, with "strong double-digit growth across online distribution channels, combined." The release ties that to innovation, existing products in key shopping moments, and higher consumer-facing investment. EUKEM and the Americas also grew organically; the company posted growth in every region for the year.

Management signal scan hits: market expansion ("targeted expanded consumer reach" across Skin Care, Fragrance, and China) and new product launches (Angels' Share on the Rocks; M·A·C door launches). The release does not claim demand exceeds supply or tight industry supply — this is a recovery narrative after a demand and channel reset, not a sold-out upcycle. Tie those quotes to the ledger: inventory fell to $1,999 million from $2,074 million while sales rose — the company is not building stock into a boom; it is turning a cleaner balance sheet into organic growth.

The Margin Story​

Gross margin expanded 150 basis points to 75.5%. The release attributes the lift to PRGP benefits — "a more competitive approach to procurement and expense optimization, as well as lower excess and obsolescence" — plus sales leverage, partly offset by inflation and incremental tariffs net of refunds. Q4 alone recorded a $38 million cost-of-sales benefit from IEEPA tariff refunds against a full-year incremental tariff gross impact of $102 million.

As-reported operating margin of 5.2% versus (5.5)% is mostly the absence of last year's impairment stack. Adjusted operating margin of 11.2% (+320 bps) is the cleaner read: operating leverage and gross-margin expansion funded "increased consumer-facing investments" while non-consumer-facing expenses stayed flat — higher incentive costs from better-than-expected performance offset by PRGP savings.

The gap between 5.2% reported and 11.2% adjusted is the FY2026 story. Restructuring and other charges, the securities contingency, and remaining one-offs still sit between the two. FY2027 guidance affirms organic net sales growth of 3% to 5% and raises adjusted operating margin outlook to 12.7%–13.5% — management is telling you the PRGP is not finished converting reported into adjusted.

Pricing language in the release is muted. The company talks investment, mix, and procurement, not "sustained increases in selling prices." Volume and brand mix are doing more work than list-price power in the words they chose.

The One Big Question: Can Reported Margin Catch Adjusted?​

Adjusted EPS of $2.51 and a 12.7%–13.5% FY2027 adjusted margin guide are the bull case numbers. Reported net income of only $182 million on $15.0 billion of sales is the bear case number. The question for FY2027 is whether restructuring charges and legal overhangs shrink fast enough for GAAP profitability to look like the adjusted story — or whether "adjusted" remains the only number that compounds.

Cash generation improved: operating cash flow was $1.773 billion versus $1.272 billion, and cash and restricted cash rose to $3.498 billion. Long-term debt fell to $6.803 billion from $7.314 billion. The balance sheet can fund the PRGP; the income statement still has to finish digesting it.

Tracking a $15B Prestige Beauty Company in Plain Text​

Double-entry forces every restructuring charge and every dollar of China growth onto the same ledger. We follow how we model every company: pad/balance the balance sheet from filings, one zero-sum income transaction per period. Income accounts are credits (negative); expenses are debits (positive).

; FY2026 Income Statement — fiscal year ended June 30, 2026
; Check: −15049 + 3687 + 0 + 9685 + 1160 + 335 + 182 = 0 ✓
 
2026-06-30 * "The Estée Lauder Companies Inc." "FY2026 Income Statement"
  Income:Revenue                         -15049 MUSD
  Expenses:CostOfRevenue                   3687 MUSD
  Expenses:ResearchAndDevelopment          0 MUSD
  Expenses:SellingGeneralAdministrative    9685 MUSD
  Expenses:OtherNet                        1160 MUSD
  Expenses:IncomeTax                        335 MUSD
  Equity:Adjustments                        182 MUSD  ; net income offset

Expenses:OtherNet of $1,160 million is where interest, restructuring, and non-operating items live after COGS and SG&A — the bridge from a 75.5% gross margin to $182 million of net income. Inventory of $1,999 million on the balance sheet is the working-capital tell: sales up, stock down.

The Multi-Year Arc​

Sales peaked in FY2022, bottomed in FY2025, and turned in FY2026. Gross margin healed before reported operating income did. Inventory has been in structural decline since FY2023 — the PRGP's obsolescence story is visible on the balance sheet, not only in the press-release adjectives.

The Verdict: Bull vs. Bear​

Bull Case

• Organic sales +3% for the year and +5% in Q4, with growth in every region and mainland China +9%.
• Adjusted operating margin +320 bps to 11.2%; FY2027 guide raised to 12.7%–13.5%.
• Fragrance +10% organic and Skin Care adjusted operating income +52% show brand power where management is investing.
• Operating cash flow $1.773B and cash $3.5B fund the plan without a distressed balance sheet.
• Inventory down to $2.0B while sales grew — working capital is cooperating with the recovery.

Bear Case

• Reported net income is only $182M; adjusted EPS of $2.51 still depends on large add-backs.
• FY2025's impairment cliff makes the YoY GAAP comparison easy; the harder bar is sequential clean GAAP.
• Makeup remains roughly flat organically; Hair Care declined.
• Effective tax rate on as-reported earnings was 64.8% — geographic mix and valuation allowances still punish GAAP.
• The release emphasizes investment and reach, not pricing power or demand exceeding supply.

Our Take: FY2026 is a real inflection in organic sales and adjusted margin, not just a base-effect bounce off impairments. The ledger shows a company that can grow again while shrinking inventory and cutting long-term debt. Until reported operating margin closes more of the gap to the 11%–13% adjusted band, treat Estée Lauder as a turnaround that has cleared the bottom — not one that has finished the repair.